These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2029165)

  • 1. Genetic polymorphisms in drug metabolism--its relevance to Asian populations.
    Lee EJ
    Ann Acad Med Singap; 1991 Jan; 20(1):56-60. PubMed ID: 2029165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
    Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.
    Morrison A; Levy R
    Pharmacogenomics; 2004 Sep; 5(6):673-89. PubMed ID: 15335288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.
    Nakamura K; Goto F; Ray WA; McAllister CB; Jacqz E; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):402-8. PubMed ID: 4042523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.
    Alván G; Bechtel P; Iselius L; Gundert-Remy U
    Eur J Clin Pharmacol; 1990; 39(6):533-7. PubMed ID: 2151318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically determined polymorphisms in drug oxidation.
    Jacqz E; Hall SD; Branch RA
    Hepatology; 1986; 6(5):1020-32. PubMed ID: 3758933
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphic drug metabolism.
    Relling MV
    Clin Pharm; 1989 Dec; 8(12):852-63. PubMed ID: 2689060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of drug transformation.
    Kalow W
    Clin Biochem; 1986 Apr; 19(2):76-82. PubMed ID: 3518992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians.
    Kiivet RA; Svensson JO; Bertilsson L; Sjöqvist F
    Pharmacol Toxicol; 1993 Feb; 72(2):113-5. PubMed ID: 8474964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Populations and genetic polymorphisms.
    Weber WW
    Mol Diagn; 1999 Dec; 4(4):299-307. PubMed ID: 10671640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms.
    Dahl ML; Llerena A; Bondesson U; Lindström L; Bertilsson L
    Br J Clin Pharmacol; 1994 Jan; 37(1):71-4. PubMed ID: 8148222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract]   [Full Text] [Related]  

  • 14. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.
    Marandi T; Dahl ML; Kiivet RA; Rägo L; Sjöqvist F
    Pharmacol Toxicol; 1996 May; 78(5):303-7. PubMed ID: 8737964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heritable polymorphisms in oxidative drug metabolism].
    Kallio J
    Duodecim; 1990; 106(5):408-14. PubMed ID: 1670108
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic polymorphism of drug metabolism in humans.
    Gross AS; Kroemer HK; Eichelbaum M
    Adv Exp Med Biol; 1991; 283():627-40. PubMed ID: 2069031
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?
    Nebert DW
    Am J Hum Genet; 1997 Feb; 60(2):265-71. PubMed ID: 9012398
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms of debrisoquine and S-mephenytoin oxidation metabolism in Chinese populations: a meta-analysis.
    Xie HG; Xu ZH; Luo X; Huang SL; Zeng FD; Zhou HH
    Pharmacogenetics; 1996 Jun; 6(3):235-8. PubMed ID: 8807662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
    Chowbay B; Zhou S; Lee EJ
    Drug Metab Rev; 2005; 37(2):327-78. PubMed ID: 15931768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debrisoquine and S-mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia.
    Marandi T; Dahl ML; Rägo L; Kiivet R; Sjöqvist F
    Eur J Clin Pharmacol; 1997; 53(3-4):257-60. PubMed ID: 9476041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.